Renovaro, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29350E1047
USD
0.65
0.29 (79.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRenovaro, Inc. VS Pharmaceuticals & Biotechnology
 
1D
79.54%
-0.51%
1W
124.62%
-1.37%
1M
104.91%
0.35%
YTD
-22.57%
0.54%
1Y
-56.58%
13.99%
3Y
-82.89%
66.39%
5Y
-84.74%
77.77%
10Y
-84.74%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.47%
0%
-25.47%
6 Months
-60.55%
0%
-60.55%
1 Year
-56.58%
0%
-56.58%
2 Years
-11.7%
0%
-11.7%
3 Years
-82.89%
0%
-82.89%
4 Years
-85.26%
0%
-85.26%
5 Years
-84.74%
0%
-84.74%

Renovaro, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary